Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases

Uta Flucke1, Rob Vogels1, Nicolas de Saint Aubain Somerhausen2, David Creytens3, Robert G. Riedl4, Joost M. van Gorp5, Anya N. Milne5, Clément J.R. Huysentruyt6, Marian A. J. Verdijk1, Monique M. van Asseldonk1, Albert Suurmeijer7, Johannes Bras8, Gabriele Palmedo9, Patricia J.T.A. Groenen1, Thomas Mentzel9
1Department of Pathology, Radboud University Medical Center, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands
2Jules Bordet Institute, Brussels, Belgium
3Department of Pathology, Ghent University Hospital, Ghent, Belgium
4Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands
5Department of Pathology, Diakonessenhuis Utrecht, Utrecht, The Netherlands
6Laboratory of Pathological Anatomy and Medical Microbiology (PAMM), Eindhoven, The Netherlands
7Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
8Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands
9Dermatopathology Bodensee, Friedrichshafen, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

Weiss SW, Enzinger FM: Epithelioid hemangioendothelioma. a vascular tumor often mistaken for a carcinoma. Cancer. 1982, 50: 970-981.

Mentzel T, Beham A, Calonje E, Katenkamp D, Fletcher CD: Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol. 1997, 21: 363-374.

Mendlick MR, Nelson M, Pickering D, Johansson SL, Seemayer TA, Neff JR, Vergara G, Rosenthal H, Bridge JA: Translocation t (1;3) (p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol. 2001, 25: 684-687.

Deyrup AT, Tighiouart M, Montag AG, Weiss SW: Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol. 2008, 32: 924-927.

Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, Flanagan J, Luo Y, Fenwick K, Natrajan R, Mitsopolous C, Zvelebil M, Hoch BL, Weiss SW, Debiec-Rychter M, Sciot R, West RB, Lazar AJ, Ashworth A, Reis-Filho JS, Lord CJ, Gerstein MB, Rubin MA, Rubin BP: Identification of disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med. 2011, 3: 98ra82

Jinghong X, Lirong C: Pulmonary epithelioid hemangioendothelioma accompanied by bilateral multiple calcified nodules in the lung. Diagn Pathol. 2011, 6: 21-

Li XM, Lin XY, Xu HT, Yu JH, Wang L, Fan CF, Liu Y, Wang EH: Mediastinal epitheloid hemangioendothelioma with abundant spindle cells and osteoclast-like giant cells mimicking malignant fibrous histiocytoma. Diagn Pathol. 2013, 8: 103-

Billings SD, Folpe AL, Weiss SW: Epithelioid sarcoma-like hemangioenothelioma. Am J Surg Pathol. 2003, 27: 48-57.

Errani C, Zhang L, Sung YS, Hajdu M, Singer S, Maki R, Healey JH, Antonescu CR: A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer. 2011, 50: 644-653.

Antonescu CR, Le Loarer F, Mosquera JM, Sboner A, Zhang L, Chen CL, Chen HW, Pathan N, Krausz T, Dickson BC, Weinreb I, Rubin MA, Hameed M, Fletcher CD: Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer. 2013, 52: 775-784.

Mitelman F, Johansson B, Mertens F: The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer. 2007, 7: 233-245.

Cheah AL, Goldblum JR, Billings SD: Molecular diagnostics complementing morphology in superficial mesenchymal tumors. Semin Diagn Pathol. 2013, 30: 95-109.

Haq R, Fisher DE: Biology and clinical relevance of the microophtalmia family of transcription factors in human cancer. J Clin Oncol. 2011, 29: 3474-3482.

Chan JK, Frizzera G, Fletcher CD, Rosai J: Primary vascular tumors of lymph nodes other than Kaposi’s sarcoma. Am J Surg Pathol. 1992, 16: 335-350.

Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, Healey JH, Ueda T, Yoshikawa H, Meloni-Ehrig A, Sorensen PH, Mertens F, Mandahl N, van den Berghe H, Sciot R, Dal Cin P, Bridge J: The der (17) t (X;17) (p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001, 20: 48-57.

Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Newbury R, Reuter VE, Garvin AJ, Perez-Atayde AR, Fletcher JA, Beckwith JB, Bridge JA, Ladanyi M: Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001, 159: 179-192.

Argani P, Aulmann S, Illei P, Netto G, Ro J, Cho HY, Dogan S, Ladanyi M, Martignoni G, Goldblum JR, Weiss SW: A distinctive subset of PEComas harbor TFE3 gene fusions. Am J Surg Pathol. 2010, 34: 1395-1406.

Malinowska I, Kwiatkowski DJ, Weiss SW, Martignoni G, Netto G, Argani P: Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biologic distinction. Am J Surg Pathol. 2012, 36: 783-784.

Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M: Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003, 27: 750-761.

Folpe AL, Chand EM, Goldblum JR, Weiss SW: Expression of Fli-1, a nuclear transcriptionfactor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol. 2001, 25: 1061-1066.

Miettinen M, Wang ZF, Paetau A, Tan SH, Dobi A, Srivastava S, Sesterhenn I: ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol. 2011, 35: 432-441.

Brenn T, Fletcher CD: Cutaneous epithelioid angiomatous nodule: a distinct lesion in the morphologic spectrum of epithelioid vascular tumors. Am J Dermatopathol. 2004, 26: 14-21.

Meis-Kindblom JM, Kindblom LG: Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 1998, 22: 683-697.

Hornick JL, Fletcher CD: Pseudomyogenic hemangioendothelioma: a distinctive, often muticentric tumor with indolent behavior. Am J Surg Pathol. 2011, 35: 190-201.

Fetsch JF, Sesterhenn IA, Miettinen M, Davis CJ: Epithelioid hemangioma of the penis. a clinicopathologic and immunohistochemical analysis of 19 cases, with special reference to exuberant examples often confused with epithelioid hemangioendothelioma and epithelioid angiosarcoma. Am J Surg Pathol. 2004, 28: 523-533.

Errani C, Zhang L, Panicek DM, Healey JH, Antonescu CR: Epithelioid hemangioma of bone and soft tissue. Clin Orthoped Relat Res. 2012, 470: 1498-1506.

Nielsen GP, Srivastava A, Kattapuram S, Deshpande V, O’Connell JX, Mangham CD, Rosenberg AE: Epithelioid hemangioma of bone revisited. a study of 50 cases. Am J Surg Pathol. 2009, 33: 270-277.

Walther C, Tayebwa J, Lilljebjorn H, Magnusson L, Nilsson J, Vult von Steyern F, Ora I, Domanski H, Fioretos T, Nord KH, Fletcher CDM, Mertens F: A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma. J Pathol. 2014, 232: 534-540.

Hornick JL, Fletcher CD: Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. Am J Surg Pathol. 2003, 27: 1183-1196.

Antonescu CR, Zhang L, Chang NE, Pawel BR, Travis W, Katabi N, Edelman M, Rosenberg AE, Nielsen GP, Dal Cin P, Fletcher CD: EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. a molecular analysis of sixty-six cases, including soft tissue, bone and visceral lesions showing common involvement of EWSR1 gene rearrangement. Genes Chromosomes Cancer. 2010, 49: 1114-1124.

Bahrami A, Dalton JD, Krane JF, Fletcher CD: A subset of cutaneous and soft tissue mixed tumors are genetically linked to their salivary gland counterpart. Genes Chromosomes Cancer. 2012, 51: 140-148.

Flucke U, Palmedo G, Blankenhorn N, Slootweg PJ, Kutzner H, Mentzel T: EWSR1 gene rearrangement occurs in a subset of cutaneous myoepithelial tumors: a study of 18 cases. Mod Pathol. 2011, 24: 1444-1450.

Antonescu CR, Zhang L, Shao SY, Mosquera JM, Weinreb I, Katabi N, Fletcher CD: Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation. Genes Chromosomes Cancer. 2013, 52: 675-682.

Meis-Kindblom JM, Bergh P, Gunterberg B, Kindblom LG: Extraskeletal myxoid chondrsarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am J Surg Pathol. 1999, 23: 636-650.

Hisaoka M, Hashimoto H: Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Pathol Int. 2005, 55: 453-463.

Chase DR, Enzinger FM: Epithelioid sarcoma. diagnosis, prognostic indicators, and treatment. Am J Surg Pathol. 1985, 9: 241-263.

Flucke U, Hulsebos TJ, van Krieken JH, Mentzel T: Myxoid epithelioid sarcoma: a diagnostic challenge. a report on six cases. Histopathology. 2010, 57: 753-759.

Hornick JL, Dal Cin P, Fletcher CD: Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol. 2009, 33: 542-550.

Den Bakker MA, Flood SJ, Kliffen M: CD31 staining in epithelioid sarcoma. Virch Arch. 2003, 443: 93-97.

Miettinen M, Wang Z, Sarlomo-Rikala M, Abdullaev Z, Pack SD, Fetsch JF: ERG expression in epithelioid sarcoma. Am J Surg Pathol. 2013, 37: 1580-1585.

Stockman DL, Hornick JL, Deavers MT, Lev DC, Lazar AJ, Wang WL: ERG and FLI1 protein expression in epithelioid sarcoma. Mod Pathol. 2014, 27: 496-501.

Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F: WHO classification of tumours of soft tissue and bone. 2013, Lyon: IARC, 39-264.

Ordóñez NG: Mesothelioma with signet ring cell features: report of 23 cases. Mod Pathol. 2013, 26: 370-384.